ASBP
Price
$0.51
Change
-$0.03 (-5.56%)
Updated
Sep 5 closing price
Capitalization
N/A
SPRO
Price
$2.15
Change
+$0.01 (+0.47%)
Updated
Sep 5 closing price
Capitalization
120.99M
72 days until earnings call
Interact to see
Advertisement

ASBP vs SPRO

Header iconASBP vs SPRO Comparison
Open Charts ASBP vs SPROBanner chart's image
Aspire Biopharma Holdings
Price$0.51
Change-$0.03 (-5.56%)
Volume$751.49K
CapitalizationN/A
Spero Therapeutics
Price$2.15
Change+$0.01 (+0.47%)
Volume$175.51K
Capitalization120.99M
ASBP vs SPRO Comparison Chart in %
Loading...
ASBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASBP vs. SPRO commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASBP is a Buy and SPRO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ASBP: $0.51 vs. SPRO: $2.15)
Brand notoriety: ASBP and SPRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASBP: 5% vs. SPRO: 25%
Market capitalization -- ASBP: $0 vs. SPRO: $120.99M
ASBP [@Biotechnology] is valued at $0. SPRO’s [@Biotechnology] market capitalization is $120.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASBP’s FA Score shows that 1 FA rating(s) are green whileSPRO’s FA Score has 1 green FA rating(s).

  • ASBP’s FA Score: 1 green, 4 red.
  • SPRO’s FA Score: 1 green, 4 red.
According to our system of comparison, SPRO is a better buy in the long-term than ASBP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASBP’s TA Score shows that 3 TA indicator(s) are bullish while SPRO’s TA Score has 5 bullish TA indicator(s).

  • ASBP’s TA Score: 3 bullish, 5 bearish.
  • SPRO’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SPRO is a better buy in the short-term than ASBP.

Price Growth

ASBP (@Biotechnology) experienced а -11.02% price change this week, while SPRO (@Biotechnology) price change was +3.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

SPRO is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRO YTD gains are higher at: 108.738 vs. ASBP (-95.549).
ASBPSPROASBP / SPRO
CapitalizationN/A121M-
EBITDAN/A-56.36M-
Gain YTD-95.549108.738-88%
P/E RatioN/A10.75-
RevenueN/A34.1M-
Total CashN/A31.2M-
Total DebtN/A3.62M-
FUNDAMENTALS RATINGS
SPRO: Fundamental Ratings
SPRO
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
7
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ASBPSPRO
RSI
ODDS (%)
Bearish Trend 1 day ago
21%
Bullish Trend 1 day ago
66%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
46%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
26%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bearish Trend 1 day ago
22%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
36%
Bullish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
38%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 4 days ago
42%
Bullish Trend 1 day ago
71%
Declines
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
24%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ASBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNMSF274.5015.00
+5.78%
Genmab A/S
WBQNL3.20N/A
N/A
Woodbridge Liquidation Trust
ASWRF0.02N/A
N/A
Gungnir Resources Inc.
BOSSY9.79N/A
N/A
Hugo Boss AG
VKSKF8.79N/A
N/A
VITAL KSK HOLDINGS INC

ASBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASBP has been loosely correlated with SPRO. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ASBP jumps, then SPRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASBP
1D Price
Change %
ASBP100%
-6.04%
SPRO - ASBP
62%
Loosely correlated
+0.47%
ALZN - ASBP
43%
Loosely correlated
+2.20%
ORIC - ASBP
29%
Poorly correlated
+1.02%
BRNS - ASBP
26%
Poorly correlated
-6.77%
CGEM - ASBP
23%
Poorly correlated
+1.16%
More

SPRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRO has been loosely correlated with ASBP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRO jumps, then ASBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRO
1D Price
Change %
SPRO100%
+0.47%
ASBP - SPRO
62%
Loosely correlated
-6.04%
CLGN - SPRO
42%
Loosely correlated
+4.31%
IMNN - SPRO
41%
Loosely correlated
+0.61%
ITOS - SPRO
35%
Loosely correlated
N/A
XENE - SPRO
32%
Poorly correlated
+1.48%
More